Used in pharmaceutical research as a key intermediate in the synthesis of serotonin receptor modulators. Shows potential in the development of central nervous system agents, particularly for neurological disorders such as depression, anxiety, and migraine. Its structural similarity to tryptamine allows it to serve as a building block in designing bioactive molecules targeting monoaminergic pathways. Also explored in the preparation of fluorescent probes for studying receptor binding and distribution in neural tissues.